Biochemical studies with a novel antifungal agent, ICI 195,739.
Barrett-Bee
K
K
ICI Pharmaceuticals Division, Macclesfield, Cheshire, England.
Lees
J
J
Pinder
P
P
Campbell
J
J
Newboult
L
L
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D001141:Aromatase / Q000378:metabolism; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D007810:Lanosterol / Q000378:metabolism; D008297:Male; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D051381:Rats; D013256:Steroids / Q000096:biosynthesis; D013261:Sterols / Q000096:biosynthesis; D013739:Testosterone / Q000097:blood; D014230:Triazoles / Q000494:pharmacology*
D000935:Antifungal Agents; D013256:Steroids; D013261:Sterols; D014230:Triazoles; C058219:ICI 195739; D007810:Lanosterol; D013739:Testosterone; D003577:Cytochrome P-450 Enzyme System; D001141:Aromatase